PRP (platelet-rich plasma) is an autologous concentrate: your blood is centrifuged to obtain a fraction with a higher concentration of platelets and signaling factors. In theory, it sounds simple; in practice, no two PRPs are identical, and that variability affects the results. Recently, reviews and studies have insisted that the concentration of platelets, the presence or absence of leukocytes, and the preparation method influence clinical efficacy—and how studies are reported.
Various authors have called for better standardization and reporting of PRP variables. The reason? Without minimal comparable data—final concentration, injected volume, leukocyte content, number of applications—it is complex to draw solid or replicable conclusions.
Traditional PRP usually lacks a standard for its application, and the calculations are primarily based on the doctor's instructions and experience. Instructions and experience from the doctor:
In 2024-2025, there are studies showing different effects of platelet concentration on pain and knee function. There are also studies that question the importance of white blood cells in some applications, which again highlights the need for better definition and measurement.
TruDOSE PRP wants to improve the way we calculate doses by using biometric data and AI: it figures out the right amount of platelets needed based on patient information, checks the actual concentration, and adjusts the volume to provide a specific dose instead of just giving "a bit of PRP." At Mitogenesis, we integrate it into personalized plans for persistent pain, recovery, or selected chronic conditions, always with realistic expectations and clinical supervision.
Key differences in procedure and patient experience
A typical consultation with TruDOSE feels less like a "one-size-fits-all" and more like a "custom-tailored suit."
This approach responds to a documented fact: platelet dosage can modify clinical outcomes; therefore, measuring and adjusting matters.
PRP—conventional or TruDOSE—does not replace surgery when it is necessary, nor does it replace habits such as sleep, strength, and nutrition.
Safety depends on proper indication, aseptic technique, and consistent product. Recent literature emphasizes that, in addition to dose/concentration, the quality of the report and standardization are key to interpreting results and guiding patient expectations.
Integration with other regenerative approaches
At Mitogenesis (Scottsdale, AZ), we work with a guiding question: what prevents your tissue from repairing? Sometimes it is poorly distributed mechanical load, other times, mitochondrial dysfunction, systemic stress, or poor sleep. That is why we combine clinical assessment, personalized interventions (like TruDOSE PRP), and education so you can measure progress realistically. Learn more about our work philosophy and why we prioritize personalization and follow-up.
PRP is not a single thing; it changes according to concentration, leukocytes, volume, and preparation. That is why dosing matters.
The main benefit of TruDOSE PRP is to turn a biological concept into a measurable and repeatable dose that is customized for your body, ensuring quality in every session.
Realistic expectations: better chances of consistency ≠ absolute promises. Integrate with rehabilitation, sleep, nutrition, and, if applicable, IVs or peptides under supervision.
Do you want an initial assessment to see if TruDOSE PRP makes sense for your case? Schedule at Mitogenesis (Scottsdale, AZ) and let us build a plan that measures what really matters to you (pain, function, and energy).
ScienceDirect: The role of platelet-rich plasma in biomedicine: A comprehensive overview (https://www.sciencedirect.com/science/article/pii/S2589004224029328)
BioMed Research International: Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies (https://onlinelibrary.wiley.com/doi/10.1155/2024/6444120)
The Journal of Bone and Joint Surgery: Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells (https://hub.jbjs.org/reader.php?rsuite_id=1285107&source=The_Journal_of_Bone_and_Joint_Surgery/99/10/809&topics=sm#info)
National Library of Medicine (NIH): Leukocytes Do Not Influence the Safety and Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis: A Double-Blind Randomized Controlled Trial (https://pmc.ncbi.nlm.nih.gov/articles/PMC11542329/)
Reviewed by:
Dr. Mel Schottenstein
Naturopathic Doctor
NMD, MBE, MScN, FICT, FSCT
Disclaimer: The information in this article is provided for informational purposes only and is not a substitute for the advice of your physician or other health care professional. Do not use the information to diagnose or treat a health problem or disease. Always consult with a healthcare professional before taking any medication or nutritional, herbal or homeopathic supplement, or using any treatment for a health problem.